Skip to main content

Table 2 Expression and circulating levels of SIRT1 and NAMPT in CHD patients and Controls

From: Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD

 

CHD patients

Controls

p-value

SIRT1 expression EAT

0.583 (0.425, 0.761)

0.529 (0.408, 0.744)

0.75

PAT

0.838 (0.636, 1.129)

0.891 (0.708, 1.129)

0.30

SAT

0.879 (0.707, 1.298)

1.143 (0.935, 1.482)

0.12

Circulating SIRT1 ng/mL

181.9 (103.8, 316.8)

143.3 (99.0, 225.6)

0.29

NAMPT expression EAT

0.653 (0.437, 0.928)

0.793 (0.434, 1.034)

0.44

PAT

0.646 (0.410, 1.078)

0.576 (0.425, 0.884)

0.76

SAT

0.827 (0.599, 1.219)

0.911 (0.727, 1.041)

0.83

Circulating NAMPT ng/mL

1.597 (1.499, 1.815)

1.630 (1.482, 1.781)

0.95

  1. Levels are median values (25, 75 percentiles)
  2. EAT, PAT, SAT; epicardial-, pericardial-, subcutaneous adipose tissue